COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:

Gallium arsenide (1303-00-0)


Study Results


Chronic Bioassay Level of Evidence

An overview of chronic evidence from Rats studies.
Rats
View
  • Clear Evidence, Female, Rats
  • No Evidence, Male, Rats
An overview of chronic evidence from Mice studies.
Mice
View
  • No Evidence, Female, Mice
  • No Evidence, Male, Mice

Genetic Toxicology

An overview of Genetic Toxicology Micronucleus Mice study conclusions related to Gallium arsenide (1303-00-0).
Micronucleus - Mice
View
  • Male: Negative
    Female: Negative
An overview of Genetic Toxicology Bacterial Mutagenicity study conclusions related to Gallium arsenide (1303-00-0).
Bacterial Mutagenicity
View
  • Negative

Citation Information


NTP. Gallium arsenide (1303-00-0). Chemical Effects in Biological Systems (CEBS). Research Triangle Park, NC (USA): National Toxicology Program (NTP).

Publications


TR-492 Toxicology and Carcinogenesis Studies of Gallium Arsenide (CASRN 1303-00-0) in F344/N Rats and B6C3F1 Mice (Inhalation Studies)
IMM90013 NTP Summary Reports on Immunotoxicology Vol. 1, No. 1-15: Immunotoxicity of Gallium Arsenide in Female B6C3F1 Mice
Zeiger, E., Anderson, B., Haworth, S., Lawlor, T., and Mortelman, K. Salmonella Mutagenicity Tests V. Results from the Testing of 311 Chemicals Environ. Molec. Mutagen. Vol. 19 (Suppl 21) (1992) 2-141
Witt, K.L., Knapton, A., Wehr, C.M., Hook, G.J., Mirsalis, J., Shelby, M.D., and MacGregor, J.T. Micronucleated Erythrocyte Frequency in Peripheral Blood of B6C3F1 Mice from Short-Term, Prechronic, and Chronic Studies of the NTP Carcinogenesis Bioassay Program. Environ. Molec. Mutagen. Vol. 36 (2000) 163-194

Study Data


Toxicity and Carcinogenicity Studies


3-Month Evaluation of the Toxicity (C62033) of Gallium Arsenide (1303-00-0) in F344 Rats via Whole Body Respiratory Exposure. NTP Special Study
3-Month Evaluation of the Toxicity (C62033) of Gallium Arsenide (1303-00-0) in B6C3F1 Mice via Whole Body Respiratory Exposure. NTP Special Study
3-Month Evaluation of the Toxicity (C62033) of Gallium Arsenide (1303-00-0) in F344/N Rats via Whole Body Respiratory Exposure
3-Month Evaluation of the Toxicity (C62033) of Gallium Arsenide (1303-00-0) in B6C3F1 Mice via Whole Body Respiratory Exposure
Evaluation of the Chronic Toxicity and Carcinogenicity (C62033B) of Gallium Arsenide (1303-00-0) in F344/N Rats via Whole Body Respiratory Exposure
Evaluation of the Chronic Toxicity and Carcinogenicity (C62033B) of Gallium Arsenide (1303-00-0) in B6C3F1 Mice via Whole Body Respiratory Exposure

Genetic Toxicology Studies


Genetic Toxicity Evaluation of Gallium Arsenide (1303-00-0) in Micronucleus Study A56833 in B6C3F1 Mice
Genetic Toxicity Evaluation of Gallium Arsenide in Salmonella/E.coli Mutagenicity Test or Ames Test. Study 006180
Summary Data

Other NTP Studies


14-Day Immunotoxicity Evaluation (IMM90013) of Gallium Arsenide (1303-00-0) in Female B6C3F1 Mice via Intratracheal Application
Toxicokinetic Evaluation (TER89143) of Gallium Arsenide (1303-00-0) in Sprague-Dawley Rats via Whole Body Respiratory Exposure
Data
Toxicokinetic Evaluation (TER90043) of Gallium Arsenide (1303-00-0) in CD-1 Mice via Whole Body Respiratory Exposure
Data